Skip to main content

Jordi Gómez i Prat

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Jordi Gómez i Prat

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Incorporació Dr. Israel Molina a la RETICS en Malalties tropicals

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Juan Espinosa Pereiro, Pau Bosch Nicolau, Nuria Serre Delcor, Fernando M Salvador Velez, Jordi Gómez i Prat, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 130542.5
Reference: RD16/0027/0003
Duration: 01/01/2017 - 30/06/2022

Movilizarse para una mayor equidad en el acceso y el ejercicio de los derechos sexuales y reproductivos en España

IP: Jordi Gómez i Prat
Collaborators: Isabel Claveria Guiu
Funding agency: Plataforma de ONG de Acción Social
Funding: 30736.61
Reference: DSSR_EEAGRANTS2013
Duration: 11/06/2014 - 30/09/2015

Knowledge Identity Language Tools (KILT) 2013]1]FR1]LEO05]48430

IP: Jordi Gómez i Prat
Collaborators: Isabel Claveria Guiu, Hakima Ouaarab Essadek
Funding agency: EUROPEAN COMMISSION
Funding: 39860.81
Reference: KILT_LIFELONGLEARNING2013
Duration: 01/10/2013 - 31/10/2015

Red de Investigación Cooperativa en Enfermedades Tropicales RICET

IP: Israel Molina Romero
Collaborators: Jose Santos Santiago, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Serre Delcor, Fernando M Salvador Velez, Augusto Cesar Sao Aviles, Jordi Gómez i Prat, Raisa Morales Martinez, Adrián Sánchez Montalvá, Elena Sulleiro Igual
Funding agency: Instituto de Salud Carlos III
Funding: 143525
Reference: RD12/0018/0020
Duration: 01/01/2013 - 30/09/2017

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Ronald Benjamin Llerena Castro

Ronald Benjamin Llerena Castro

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructure
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.